Diagnostic performance of non-invasive markers of fibrosis compared with liver biopsy in MASLD patients in tertiary care centre

International Journal of Medical and Biomedical Studies 2026 Open access

Read full text
Authors: M. Udaya Kumar, Bikash Narayan Choudhury, Mallika Bhattacharyya, Sandeep Saini, Usha Sharma, U.J Deka, B.J Baruah
DOI: 10.32553/ijmbs.v10i1.3192
Cited by: 0

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects a significant proportion of the global population, with a subset progressing to advanced fibrosis carrying risks of portal hypertension and hepatocellular carcinoma. Non-invasive tests (NITs) including liver stiffness measurement (LSM), FIB-4, NAFLD Fibrosis Score (NFS), and APRI are increasingly used for fibrosis assessment, yet their diagnostic accuracy varies across populations and phenotypes, including lean MASLD

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Liver Diseases and Immunity

Publication details

Journal / source
International Journal of Medical and Biomedical Studies
Volume
10
Issue
1
Pages
32–44
Publication date
27 February 2026
Language
EN